Document is current
Any future updates will be listed below
-
Authors
Arboleda-Velasquez, Joseph F. http://orcid.org/0000-0002-3192-9117
Lopera, Francisco
O’Hare, Michael
Delgado-Tirado, Santiago
Marino, Claudia
Chmielewska, Natalia
Saez-Torres, Kahira L.
Amarnani, Dhanesh
Schultz, Aaron P.
Sperling, Reisa A.
Leyton-Cifuentes, David http://orcid.org/0000-0002-7450-4207
Chen, Kewei
Baena, Ana
Aguillon, David
Rios-Romenets, Silvia
Giraldo, Margarita
Guzmán-Vélez, Edmarie
Norton, Daniel J.
Pardilla-Delgado, Enmanuelle http://orcid.org/0000-0003-1149-3157
Artola, Arabiye
Sanchez, Justin S.
Acosta-Uribe, Juliana
Lalli, Matthew http://orcid.org/0000-0003-0419-1206
Kosik, Kenneth S.
Huentelman, Matthew J.
Zetterberg, Henrik
Blennow, Kaj
Reiman, Rebecca A.
Luo, Ji
Chen, Yinghua
Thiyyagura, Pradeep
Su, Yi
Jun, Gyungah R.
Naymik, Marcus
Gai, Xiaowu
Bootwalla, Moiz
Ji, Jianling http://orcid.org/0000-0003-4941-3538
Shen, Lishuang http://orcid.org/0000-0002-0436-0199
Miller, John B.
Kim, Leo A. http://orcid.org/0000-0001-9106-6416
Tariot, Pierre N. http://orcid.org/0000-0002-6058-8032
Johnson, Keith A.
Reiman, Eric M. http://orcid.org/0000-0002-0705-3696
Quiroz, Yakeel T. http://orcid.org/0000-0001-9714-8244
- License Information
-
More Information
Article History
Received: 10 January 2019
Accepted: 12 September 2019
First Online: 4 November 2019
Competing interests
: P.N.T. has received personal compensation for consulting, serving on scientific advisory boards, and other activities from AbbVie, AC Immune, Acadia, Auspex, Boehringer Ingelheim, Chase Pharmaceuticals, Corium, Eisai, GliaCure, INSYS Therapeutics, Pfizer, T3D, AstraZeneca, Avanir, Biogen, Eli Lilly, H. Lundbeck A/S, Merck and Company and Roche; holds a provisional patent on ‘Biomarkers of Alzheimer’s Disease’ at the University of Rochester; holds stock options in Adamas; received research support from AstraZeneca, Avanir, Biogen, Eli Lilly, H. Lundbeck A/S, Merck and Company, Roche, Amgen, Avid, Functional Neuromodulation, GE Healthcare, Genentech, Novartis, Takeda, Targacept, the National Institute on Aging and the Arizona Department of Health Services. H.Z. has served on scientific advisory boards for Roche Diagnostics, Wave, Samumed, and CogRx, has given lectures in symposia sponsored by Biogen and Alzecure and is a co-founder of Brain Biomarker Solutions, a GU Ventures-based platform company at the University of Gothenburg (outside submitted work). R.A.S. has received personal compensation from AC Immune, Eisai, Roche, and Takeda, and research grant support from Eli Lilly and Janssen. All other authors have no competing interests.
